Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North Atlantic Value LLP is a UK-based investment management firm that specializes in identifying undervalued companies, often taking activist positions to drive corporate change and value creation. While not a biotechnology developer itself, the firm is a significant player in the life sciences sector through its strategic investments in pharmaceutical, medical technology, and healthcare services companies. Led by prominent investor Christopher Mills, the group manages the North Atlantic Smaller Companies Investment Trust (NASCIT) and has historically held influential stakes in companies such as Sinclair Pharma, EUSA Pharma, and Consort Medical. The firm's approach typically involves long-term capital commitment and active engagement with management teams to optimize operational performance and strategic direction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Atlantic Value Group.